Skip to main content
Back

chapter 20 study guide

Control buttons has been changed to "navigation" mode.
1/20
  • Sources of antibiotics based on microbial antagonism

    Antibiotics are commonly sourced from Streptomyces (soil bacteria), Bacillus species, and Penicillium (a fungus).

  • Definition of selective toxicity

    Selective toxicity means an antimicrobial kills or inhibits microbes without harming the host cells.

  • What is an antibiotic?

    An antibiotic is a natural or synthetic chemical that kills or inhibits bacteria.

  • Broad spectrum vs narrow spectrum antibiotics

    Broad spectrum antibiotics act against many bacteria types; narrow spectrum target specific bacteria.

  • What is a superinfection?

    A superinfection occurs when broad spectrum antibiotics kill normal flora, allowing resistant pathogens to grow.

  • Difference between bactericidal and bacteriostatic

    Bactericidal drugs kill bacteria; bacteriostatic drugs inhibit bacterial growth.

  • Meaning of MIC and MBC

    MIC is the minimum inhibitory concentration that stops growth; MBC is the minimum bactericidal concentration that kills bacteria.

  • Advantages of narrow spectrum antibiotics

    They target specific pathogens, reducing damage to normal flora and lowering superinfection risk.

  • Disadvantages of broad spectrum antibiotics

    They can disrupt normal flora and promote resistance and superinfections.

  • Criteria for selecting an antimicrobial

    Consider pathogen identity, drug toxicity, drug concentration at infection site, patient health, and cost.

  • Five mechanisms antimicrobials use to inhibit or kill bacteria

    Inhibit cell wall synthesis, protein synthesis, nucleic acid synthesis, cell membrane integrity, or metabolic pathways.

  • Example of cell wall synthesis inhibitor antibiotic

    Penicillin inhibits bacterial cell wall synthesis by blocking peptidoglycan cross-linking.

  • Example of protein synthesis inhibitor antibiotic

    Tetracycline binds the 30S ribosomal subunit, blocking tRNA attachment and protein synthesis.

  • Why is developing drugs against eukaryotes challenging?

    Because human cells are eukaryotic, making it hard to target pathogens without harming host cells.

  • How do antiviral drugs work?

    They inhibit viral entry, replication, or release from host cells.

  • Three antiviral approaches studied for SARS-CoV-2

    Inhibiting viral entry, blocking viral RNA polymerase, and preventing viral protease activity.

  • Methods to test antibiotics in the lab

    Disk diffusion (Kirby-Bauer), broth dilution for MIC, and MBC tests.

  • What is drug resistance?

    Drug resistance is when microbes survive antimicrobial treatment due to genetic changes or acquired mechanisms.

  • Four molecular mechanisms of drug resistance

    Enzymatic drug inactivation, target modification, decreased permeability, and efflux pumps.

  • Behaviors promoting drug resistance

    Overuse, misuse of antibiotics, incomplete treatment courses, and use in agriculture.